Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-26-001962
Filing Date
2026-03-31
Accepted
2026-03-31 16:03:22
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 6934
  Complete submission text file 0001178913-26-001962.txt   8612
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address TWO COMMERCE SQUARE, 2001 MARKET STREET 28TH FLOOR PHILADELPHIA PA 19103
Business Address
Quigley Jill M. (Reporting) CIK: 0001799780 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 26821564